Mettler-Toledo International Inc (MTD)
1483.09
+3.79
(+0.26%)
USD |
NYSE |
May 24, 15:43
Mettler-Toledo International Free Cash Flow: 903.08M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 903.08M |
| December 31, 2023 | 860.55M |
| September 30, 2023 | 883.08M |
| June 30, 2023 | 858.35M |
| March 31, 2023 | 796.21M |
| December 31, 2022 | 737.83M |
| September 30, 2022 | 669.53M |
| June 30, 2022 | 691.80M |
| March 31, 2022 | 738.66M |
| December 31, 2021 | 801.24M |
| September 30, 2021 | 813.73M |
| June 30, 2021 | 777.59M |
| March 31, 2021 | 719.80M |
| December 31, 2020 | 632.20M |
| September 30, 2020 | 592.40M |
| June 30, 2020 | 536.61M |
| March 31, 2020 | 476.33M |
| December 31, 2019 | 506.11M |
| September 30, 2019 | 482.62M |
| June 30, 2019 | 448.27M |
| March 31, 2019 | 451.95M |
| December 31, 2018 | 422.28M |
| September 30, 2018 | 393.26M |
| June 30, 2018 | 387.22M |
| March 31, 2018 | 389.10M |
| Date | Value |
|---|---|
| December 31, 2017 | 388.90M |
| September 30, 2017 | 346.13M |
| June 30, 2017 | 360.13M |
| March 31, 2017 | 356.23M |
| December 31, 2016 | 336.80M |
| September 30, 2016 | 380.30M |
| June 30, 2016 | 362.95M |
| March 31, 2016 | 344.39M |
| December 31, 2015 | 357.29M |
| September 30, 2015 | 345.76M |
| June 30, 2015 | 343.53M |
| March 31, 2015 | 343.45M |
| December 31, 2014 | 329.52M |
| September 30, 2014 | 299.99M |
| June 30, 2014 | 299.58M |
| March 31, 2014 | 285.05M |
| December 31, 2013 | 263.58M |
| September 30, 2013 | 260.84M |
| June 30, 2013 | 241.15M |
| March 31, 2013 | 234.50M |
| December 31, 2012 | 232.12M |
| September 30, 2012 | 220.91M |
| June 30, 2012 | 198.16M |
| March 31, 2012 | 195.68M |
| December 31, 2011 | 182.38M |
Free Cash Flow Range, Past 5 Years
448.27M
Minimum
Jun 2019
903.08M
Maximum
Mar 2024
696.30M
Average
728.81M
Median
Free Cash Flow Benchmarks
| Natera Inc | -186.98M |
| Exact Sciences Corp | -20.46M |
| Illumina Inc | 366.00M |
| Waters Corp | 514.03M |
| Castle Biosciences Inc | -6.457M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 189.99M |
| Cash from Investing (Quarterly) | -8.935M |
| Cash from Financing (Quarterly) | -179.08M |
| Free Cash Flow Per Share (Quarterly) | 8.012 |
| Free Cash Flow to Equity (Quarterly) | 166.69M |
| Free Cash Flow to Firm (Quarterly) | 188.08M |
| Free Cash Flow Yield | 2.79% |